Aptose Biosciences
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $52,356,000.
Profit Margin
| 2014 | 0 | -11.50M | |
|---|---|---|---|
| 2015 | 0 | -10.53M | |
| 2016 | 0 | -13.85M | |
| 2017 | 0 | -11.66M | |
| 2018 | 0 | -28.86M | |
| 2019 | 0 | -25.69M | |
| 2020 | 0 | -54.70M | |
| 2021 | 0 | -65.26M | |
| 2022 | 0 | -41.05M | |
| 2023 | 0 | -51.20M |
APS.TO Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 36.76M | 28.08M | 45.98M | 29.28M | 16.83M | 18.73M | 6.27M | 7.67M | 4.50M | 3.55M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 52.35M | 42.60M | 65.44M | 55.76M | 26.85M | 29.10M | 11.82M | 13.88M | 11.60M | 11.83M |
Operating income | -52.35M | -42.59M | -65.44M | -55.77M | -26.86M | -29.06M | -11.75M | -13.83M | -11.40M | -11.76M |
Other income (expenses), net | 1.14M | 770K | 92K | 530K | 586K | -44K | 97K | -49.10K | -302.83K | 259.05K |
Income before tax | -51.20M | -41.82M | -65.35M | -55.23M | -26.27M | -28.86M | -11.66M | -13.85M | -10.53M | -11.50M |
Income tax expense | 0 | -770K | -93K | -530K | -580K | -195K | -97K | -29.01K | -886.36K | 0 |
Net income | -51.20M | -41.05M | -65.26M | -54.70M | -25.69M | -28.86M | -11.66M | -13.85M | -10.53M | -11.50M |
Earnings per share | ||||||||||
Basic EPS | -7.58 | -0.44 | -10.99 | -10.03 | -7.68 | -12.97 | -7.84 | -16.31 | -13.28 | -14.88 |
Diluted EPS | -7.58 | -0.44 | -10.99 | -10.03 | -7.68 | -12.97 | -7.84 | -16.31 | -13.28 | -14.87 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |